Pharmi바카라사이트 추천 accelerates CDMO expansion through growth of 바카라사이트 추천s handled by human 바카라사이트 추천 management business
Expanding CDMO sales to advanced regenerative medical devices with the capability to handle 7 바카라사이트 추천 types
[by Kang, In Hyo] Pharmi바카라사이트 추천 announced on May 27 that it has completed the expansion of the scope of ‘바카라사이트 추천s handled by human 바카라사이트 추천 management business,’ with the aim to expand its contract development and manufacturing (CDMO) capabilities for 바카라사이트 추천 therapy.
With the inclusion of additional 바카라사이트 추천 types, Pharmi바카라사이트 추천 is now equipped to manage a total of seven 바카라사이트 추천 types, including bone marrow-derived mononuclear 바카라사이트 추천s, as well as autologous and allogeneic mesenchymal stem 바카라사이트 추천s (MSCs) derived from bone marrow, adipose tissue, and umbilical cord sources. This development has notably enhanced the company’s capacity for 바카라사이트 추천 manufacturing and supply. Pharmi바카라사이트 추천 emphasized that this advancement lays a foundational framework for full-scale implementation of its CDMO operations, specifically aimed at supporting regenerative medicine institutions.
Pharmi바카라사이트 추천 stated that, in addition to 바카라사이트 추천 manufacturing and supply, it also offers contract testing services like sterility testing, mycoplasma contamination testing, and exogenous virus detection. Through the establishment of a comprehensive quality management system, the company has secured differentiated competitiveness as a CDMO partner in the field of 바카라사이트 추천 therapy.
According to Pharmi바카라사이트 추천, the company has over two decades of experience in the production and quality management of stem 바카라사이트 추천 therapies. Pharmi바카라사이트 추천 is equipped with advanced GMP-compliant manufacturing facilities, a robust production infrastructure grounded in human 바카라사이트 추천 management, highly skilled professional personnel, and a well-established system for testing and evaluation.
Leveraging these capabilities, Pharmi바카라사이트 추천 is positioning itself as a specialized CDMO organization that covers the entire development cycle, from early-stage R&D to clinical trials and commercialization. The company stated that it intends to further reinforce its role as a strategic partner in the Korean and international advanced regenerative medicine industry, grounded in its advanced manufacturing system and quality management capabilities.
“We intend to provide comprehensive support to advanced regenerative medicine institutions, encompassing clinical research, 바카라사이트 추천 therapy manufacturing process development, establishment of quality management systems, and therapeutic consulting,” a Pharmi바카라사이트 추천 official stated. “We will actively leverage our specialized mesenchymal stem 바카라사이트 추천 culture medium, ‘PharmiSTEM hMSC Media,’ to spearhead the rapidly growing advanced regenerative medicine market.”